Literature DB >> 8383290

Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders.

M B Bromberg1, J W Albers.   

Abstract

The pattern of an abnormal median-normal sural (AMNS) sensory response is associated with acute and chronic inflammatory demyelinating polyradiculoneuropathy (AIDP and CIDP) and considered unusual in other types of neuropathy, although specificity and sensitivity of this pattern have not been evaluated. We compared sensory responses (patterns and absolute values) in patients with AIDP, CIDP, diabetic polyneuropathy (DP), and motor neuron disease (MND). Using strict criteria, the AMNS pattern occurred more frequently in recent onset AIDP (39%) compared with CIDP (28%), DP (14%-23%), or MND (22%) patients. This pattern was found in 3% of control subjects. The extreme pattern of an absent median-present sural response occurred only in AIDP and CIDP patients and in no other groups. Abnormalities of both nerves were more common in long-standing polyneuropathies such as CIDP and DP compared with AIDP or MND. Median nerve amplitudes were reduced significantly in AIDP, CIDP, and DP patients compared with MND patients, whereas sural nerve amplitudes were significantly reduced only in DP and CIDP patients. These findings may reflect early distal nerve involvement particularly in AIDP patients which is highlighted by differences in median and sural nerve recording electrode placement. We conclude that, in the appropriate clinical setting, the AMNS pattern, an absent median-present sural response pattern, or a reduced median amplitude compared with the sural amplitude supports a diagnosis of a primary demyelinating polyneuropathy.

Entities:  

Mesh:

Year:  1993        PMID: 8383290     DOI: 10.1002/mus.880160304

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Nerve conduction and electromyography studies.

Authors:  N M Kane; A Oware
Journal:  J Neurol       Date:  2012-05-22       Impact factor: 4.849

2.  Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.

Authors:  S Kuwabara; S Misawa; M Mori; N Tamura; M Kubota; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

3.  Response to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy with only sensory symptoms.

Authors:  G W van Dijk; N C Notermans; H Franssen; P L Oey; J H Wokke
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

Review 4.  Guillain-barré syndrome.

Authors:  Satoshi Kuwabara
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

5.  Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy.

Authors:  S Kuwabara; K Ogawara; S Misawa; M Mori; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 6.  Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.

Authors:  E Ellie; A Vital; A Steck; J M Boiron; C Vital; J Julien
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

Review 7.  Entrapment neuropathies in diabetes mellitus.

Authors:  Eugenia Rota; Nicola Morelli
Journal:  World J Diabetes       Date:  2016-09-15

Review 8.  Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors:  Amanda C Peltier; Peter D Donofrio
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

9.  Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?

Authors:  Pierre Lozeron; Vincent Ribrag; David Adams; Marion Brisset; Marguerite Vignon; Marine Baron; Marion Malphettes; Marie Theaudin; Bertrand Arnulf; Nathalie Kubis
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

Review 10.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.